Please note: registration is limited to representatives of funding and philanthropy serving organizations.

Advocacy is one of the most underfunded areas of HIV philanthropy—yet essential to defending rights and sustaining progress.

Join Funders Concerned About AIDS (FCAA) on Wednesday, November 12, 2025, from 10:00–11:30 AM EST for From Courtrooms to Communities: Funding Advocacy to Protect HIV Responses.

Moderator

• Marvell L. Terry II, Funders Concerned About AIDS (FCAA) 

Featured Speakers

• S. Mandisa Moore O’Neal, Center for HIV Law & Policy (CHLP)
• Mitchell Warren, AVAC 
• Edwin J. Bernard, HIV Justice Network

Together, they will explore how shifting legal and policy environments are shaping HIV responses, why bold and intersectional advocacy strategies matter, and where philanthropy can make catalytic investments to protect and advance progress.

The People’s Declaration—currently with over 500 signatories, charts out a number of community priorities and demands—as noted below. Please join The Choice Agenda, The Legacy Project, and a fabulous global panel to discuss moving those demands into actions and accountability.

To date, the discourse surrounding these actions has focused largely on the devastation to grants, dollars, and institutions. Here, we center people instead—the communities who stand to suffer the harshest consequences of these actions. Here, we remind the world that the first letter in HIV stands for human.

• We demand substantive, meaningful inclusion of community in every aspect of HIV research, from protocol development to study implementation to the dissemination of clinical trial results.
• We demand diversity, equity, and inclusion amongst the scientific teams conducting HIV research.
• We demand diversity, equity, and inclusion across all community stakeholder engagement activities.
• We demand diversity, equity, and inclusion in the recruitment of clinical trial participants who accurately reflect the epidemic.

Click to read the full declaration and sign on if you haven’t already!

Moderator

• Brian Minalga, Office of HIV/AIDS Network Coordination (HANC)

Panelists

• Adrian Williams, Florida State University, Institute on Digital Health & Innovation & AW DEI Consulting Inc
• Asia Russell, Health GAP JD Davids, JD Strategies, Patient Led Research Collaborative
• Luciana Kamel, HIV Community Advocate, Brazil
• Moses Supercharger, Joint Adherent Brothers and Sisters Against AIDS, Uganda
• Rebecca Denison, Advocate, USA

PEPFAR launched its “Bridge Planning” process on September 5, with country plans due September 25 and approval by September 30. This fast timeline risks excluding community and civil society voices, despite their critical role in shaping effective, sustainable HIV responses. Reports indicate limited to no community participation in many African partner countries, undermining rights-based, participatory planning.

Eannaso is hosting this emergency webinar to convene stakeholders to strategize collective advocacy for meaningful civil society engagement in this urgent process.

Over the past four decades, HIV research has saved tens of millions of lives through discoveries in HIV treatment and prevention, with the US federal government playing a foundational role in that success. Unprecedented assaults on science and research and the systematic dismantling of federal institutions over the past months risk those accomplishments. These unparalleled budget cuts and project terminations will set the HIV/AIDS response back years, if not decades.

It’s not too late to change that! The commitment and actions of the scientific and advocacy community have been successful in reversing some of these funding decisions and we need to keep up the pressure.

Join us on September 16 starting at 11:00 ET as scientists, researchers, and advocates from around the world describe what has been achieved through decades of federal investments and what we stand to lose. Don’t miss the opportunity to come together in community as we share insights, answer questions, and inspire action.

Join the UNITED! Movement and AVAC to learn more about the future of HIV prevention and what this means for young people. The webinar will cover:

• Prevention options currently available
• Long-acting PrEP products, including those currently available, available soon, and in the pipeline
• An update on the introduction of six month lenacapavir for PrEP
• Advocacy priorities for long-acting PrEP research and rollout, with a focus on what these mean for youth
• Experiences from youth advocates involved with PrEP introduction and rollout

The session will also include time for Q&A with speakers.

Join an engaging session on the Dual Prevention Pill (DPP), featuring Kate Segal (AVAC), Barbara Friedland (Population Council), and Wawira Nyagah (AVAC). Speakers will highlight the product pipeline, the regulatory pathway, and the implementation agenda ahead—followed by a panel discussion with leading experts driving progress in MPTs.

This webinar will provide participants with scientific, policy, funding and community highlights from IAS 2025, the 13th IAS Conference on HIV Science, held in Kigali, Rwanda, in July. Attendees will gain a clearer understanding of the latest trends and emerging priorities in the global HIV response and hear reflections from stakeholders, including community voices.

Moderators

• Kenneth Ngure, School of Public Health, Jomo Kenyatta University of Agriculture and Technology and IAS — The International AIDS Society, Kenya
• Susan Shumba, Young Advocates for Inclusion Network and IAS — The International AIDS Society, Zimbabwe

Speakers

• Alexandra Calmy, Geneva University Hospitals (HUG) and IAS, Switzerland
• Gaston Devisich, Fundación Huésped, Argentina
• Doreen Moraa Moracha, Kenya

This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis.

Thursday 28 August 2025 at 13:00 – 14:00 Geneva-time

Times in your location: 7:00 EDT / 12:00 WAT / 13:00 CEST / 13:00 SAST / 14:00 EEST / 16:30 IST / 18:00 ICT / 19:00 PHST

After registering, you will receive a confirmation email containing information about joining the webinar.

This is the first webinar in a three-part series: 

• Part 2 on 4 September 2025 focus on HIV testing (in partnership with PSI)
• Part 3 will focus on e-training for PrEP providers (in partnership with Jhpiego)

Further details about these webinars will be shared soon!